AIP
INSM icon

Arrowpoint Investment Partners’s Insmed INSM Stock Holding History

Arrowpoint Investment Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Buy
30,170
+23,152
+330% +$2.8M 0.7% 21
2026
Q1 		$1.15M Sell
7,018
-4,538
-39% -$698K 1.02% 22
2025
Q4 		$2.01M Buy
+11,556
New +$2.11M 0.3% 28

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Arrowpoint Investment Partners's INSM Position: Q2 2026 in Review

Arrowpoint Investment Partners increased its Insmed (INSM) stake by 330% in Q2 2026, buying an estimated $2.8M and bringing the position to 30,170 shares worth $3.22M. The position accounts for 0.7% of the portfolio, ranked #21.

Arrowpoint Investment Partners first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Arrowpoint Investment Partners held 30,170 shares of Insmed worth $3.22M as of Q2 2026.
  • Arrowpoint Investment Partners bought 23,152 Insmed shares in Q2 2026, an estimated $2.8M.
  • Insmed made up 0.7% of Arrowpoint Investment Partners's portfolio in Q2 2026, its #21 holding.
  • Arrowpoint Investment Partners first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.